Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

被引：0

作者：

Yanink Caro-Vega

Anna Schultze

Anne Marie W. Efsen

Frank A. Post

Alexander Panteleev

Aliaksandr Skrahin

Jose M. Miro

Enrico Girardi

Daria N. Podlekareva

Jens D. Lundgren

Juan Sierra-Madero

Javier Toibaro

Jaime Andrade-Villanueva

Simona Tetradov

Jan Fehr

Joan Caylà

Marcelo H. Losso

Robert F. Miller

Amanda Mocroft

Ole Kirk

Brenda Crabtree-Ramírez

机构：

[1] Instituto Nacional de Ciencias Médicas y Nutrición,Department of Infectious Diseases

[2] Salvador Zubirán,Department of Infection and Population Health

[3] University College London Medical School,Centre for Health and Infectious Disease Research (CHIP), Department of Infectious Diseases, Finsencentret, Rigshospitalet

[4] University of Copenhagen,Department of Sexual Health, Caldecot Centre

[5] King’s College Hospital,Clinical Department

[6] Department of HIV/TB,Department of Infectious Diseases INMI “L. Spallanzani”

[7] TB hospital 2,Infectious Diseases Service

[8] Republican Research and Practical Centre for Pulmonology and TB,Dr Victor Babes’ Hospital of Tropical and Infectious Diseases

[9] Infectious Diseases Service,Division of Infectious Diseases and Hospital Epidemiology

[10] Hospital Clinic – IDIBAPS. University of Barcelona,Centre for Clinical Research in Infection and Sexual Health, Institute for Global Health

[11] Ospedale L Spallanzani,undefined

[12] HIV Unit,undefined

[13] Hospital J.M. Ramos Mejia and CICAL,undefined

[14] Fundación IBIS,undefined

[15] Hospital Civil de Guadalajara,undefined

[16] Bucharest AND ‘Carol Davila’ University of Medicine and Pharmacy,undefined

[17] University Hospital Zurich,undefined

[18] Agencia de Salud Pública de Barcelona: Programa Integrado de Investigación en Tuberculosis de SEPAR (PII-TB); Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP),undefined

[19] University College London,undefined

来源：

BMC Infectious Diseases | / 18卷

关键词：

HIV; Tuberculosis; ART; Efavirenz; Protease inhibitor; Outcomes; Eastern Europe;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 141 条

[1]

Podlekareva DN(2009)Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina AIDS 23 2485-2495

[2]

Mocroft A(2016)Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study Lancet HIV 3 e120-e131

[3]

Post FA(2001)Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa AIDS 15 143-152

[4]

Riekstina V(2009)Risk and prognostic significance of tuberculosis in patients from the TREAT Asia HIV observational database BMC Infect Dis 9 46-2002

[5]

Miro JM(2015)Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis AIDS 29 1987-1491

[6]

Furrer H(2015)Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding Glob Health Action 8 27048-1481

[7]

Podlekareva DN(2016)Integrated therapy for HIV and tuberculosis AIDS Res Ther 13 22-1501

[8]

Efsen AM(2011)Timing of antiretroviral therapy for HIV-1 infection and tuberculosis N Engl J Med 365 1482-706

[9]

Schultze A(2011)Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis N Engl J Med 365 1471-218

[10]

Post FA(2011)Integration of antiretroviral therapy with tuberculosis treatment N Engl J Med 365 1492-796

← 1 2 3 4 5 6 7 8 9 10 →